---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-006554"
form_type: "8-K"
ticker: "ALLR"
cik: "0001860657"
company_name: "Allarity Therapeutics, Inc."
filed_at: "2024-01-25T23:59:59+00:00"
generated_at: "2026-06-06T18:32:02.059580+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Allarity Therapeutics amends registration rights provision in securities purchase agreement with 3i, LP

## Summary
- Amendment to Securities Purchase Agreement dated Jan 18, 2024, for up to $1.54M in senior convertible notes.
- Demand registration rights clarified: Purchaser can request registration starting 90 days after First Closing Date.
- Company must file registration statement within 15 days of request and use best efforts to make effective within 45 days.
- No other changes; original agreement remains in full force.

## SEC filing metadata
- accession: 0001213900-24-006554
- form_type: 8-K
- ticker: ALLR
- cik: 0001860657
- company_name: Allarity Therapeutics, Inc.
- filed_at: 2024-01-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860657/000121390024006554/0001213900-24-006554-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860657/000121390024006554/ea192203-8k_allarity.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-006554
- JSON: https://secwatch.observer/filing/0001213900-24-006554.json
- Plain text: https://secwatch.observer/filing/0001213900-24-006554.txt

## Key facts
- Material Agreements
  Allarity Therapeutics, Inc. amended Amendment with 3i, LP (effective 2024-01-25).
  - Action: amendment
  - Agreement: equity purchase
  - Counterparty: 3i, LP
  - Effective: 2024-01-25
  source text: On January 25, 2024, Allarity Therapeutics, Inc., a Delaware corporation (“we,” “our,” or the “Company”) and 3i, LP, a Delaware limited partnership (the “Purchaser”), executed an amendment (the “Amendment”) to that certain Securities Purchase Agreement dated as of January 18, 2024 (the “Original Agreement”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860657/000121390024006554/0001213900-24-006554-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.